Fupidine mRNA vaccine arrives in Hong Kong, China

Fupidine mRNA vaccine arrives in Hong Kong, China
Fosun Pharma and Biontech jointly developed Forbitide mRNA vaccine, which was delivered to the Hong Kong Special Administrative Region on July 7. About 758,000 doses of the vaccine have arrived in Hong Kong, bringing the total to about 1.343 million doses of Fobetai vaccine delivered at the end of last month to 585,000 doses.

Biontech’s mRNA coronavirus vaccine has met all primary efficacy endpoints and is 95% effective in preventing novel coronavirus infection, according to Phase III clinical trial results.